664 related articles for article (PubMed ID: 27865851)
1. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
2. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease.
Shavali S; Combs CK; Ebadi M
Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
4. The role of Galectin-3 in α-synuclein-induced microglial activation.
Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
[TBL] [Abstract][Full Text] [Related]
5. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
6. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
[TBL] [Abstract][Full Text] [Related]
7. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease.
Olanow CW; Savolainen M; Chu Y; Halliday GM; Kordower JH
Brain; 2019 Jun; 142(6):1690-1700. PubMed ID: 31056668
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
[TBL] [Abstract][Full Text] [Related]
10. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
12. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
13. The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.
Badanjak K; Fixemer S; Smajić S; Skupin A; Grünewald A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925154
[TBL] [Abstract][Full Text] [Related]
14. Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease.
Kumar A; Leinisch F; Kadiiska MB; Corbett J; Mason RP
Mol Neurobiol; 2016 Jul; 53(5):2983-2994. PubMed ID: 25952542
[TBL] [Abstract][Full Text] [Related]
15. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
Reynolds AD; Glanzer JG; Kadiu I; Ricardo-Dukelow M; Chaudhuri A; Ciborowski P; Cerny R; Gelman B; Thomas MP; Mosley RL; Gendelman HE
J Neurochem; 2008 Mar; 104(6):1504-25. PubMed ID: 18036154
[TBL] [Abstract][Full Text] [Related]
16. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
17. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
18. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
Kuter KZ; Śmiałowska M; Ossowska K
Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
[TBL] [Abstract][Full Text] [Related]
19. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
[TBL] [Abstract][Full Text] [Related]
20. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
Zheng T; Zhang Z
Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
